Skip to content
OpenCapital
Get started

Vera Therapeutics VERA Q4 2024 Annual earnings

Reported February 26, 2025 · Before market open

EPS-$0.72Beat by $0.11
EPS estimate-$0.83

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$1.3M
EPS estimate-$1.60

Financials

Q4 2024

Income statement

See full
Operating income-$48.9M-81.0%
Net income-$43.4M-69.3%
EPS (diluted)-$0.72-24.1%

Balance sheet

See full
Cash & equivalents$92.6M+103%
Total debt$54.6M+1.7%
Total equity$577.2M+468%
Total assets$655.7M+274%

Cash flow

See full
Operating cash flow-$39.2M-55.8%
CapEx$645.0K+924%
Free cash flow-$39.8M-58.0%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$2.68B+292%
Enterprise value$2.64B+282%

Returns & leverage

See full
Return on equity-44.8%-16.5pp
Debt / equity0.1×-0.4×
Current ratio25.7×+18.0×

Versus estimates

Diluted EPS

Q1 2026-$1.69Miss by $0.36Q4 2025-$1.39Miss by $0.05Q3 2025-$1.26Miss by $0.06Q2 2025-$1.20Miss by $0.38Q1 2025-$0.81Miss by $0.06
Q4 2024-$0.72Beat by $0.11

Ask the moment Vera Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vera Therapeutics report Q4 2024 earnings?
Vera Therapeutics (VERA) reported Q4 2024 earnings on February 26, 2025 before market open.
What were Vera Therapeutics's Q4 2024 revenue and EPS?
Vera Therapeutics reported eps of $-0.72 for Q4 2024.
Did Vera Therapeutics beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.83 by $0.11.
Where can I find Vera Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-029969) directly on SEC EDGAR. The filing index links above go to sec.gov.